PL2571488T5 - Kompozycja farmaceutyczna ibuprofenu do iniekcji - Google Patents

Kompozycja farmaceutyczna ibuprofenu do iniekcji

Info

Publication number: PL2571488T5
Authority: PL; Poland
Prior art keywords: ibuprofen; injection; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2010-05-18

Application number

PL11720479T

Other languages

English (en)

Other versions

PL2571488T3 (pl

Inventor

Ignacio ORTÚZAR ANDÉCHAGA

Mario ORTÚZAR GUTIÉRREZ

Original Assignee

Genfarma Laboratorio S.L.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-05-18

Filing date

2011-05-18

Publication date

2018-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43589415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2571488(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-05-18 Application filed by Genfarma Laboratorio S.L. filed Critical Genfarma Laboratorio S.L.

2014-12-31 Publication of PL2571488T3 publication Critical patent/PL2571488T3/pl

2018-07-31 Publication of PL2571488T5 publication Critical patent/PL2571488T5/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL11720479T 2010-05-18 2011-05-18 Kompozycja farmaceutyczna ibuprofenu do iniekcji PL2571488T5 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/ES2010/070330 WO2011144766A1 (es)	2010-05-18	2010-05-18	Composición farmacéutica de ibuprofeno para inyección
EP11720479.2A EP2571488B2 (en)	2010-05-18	2011-05-18	Pharmaceutical composition of ibuprofen for injection
PCT/EP2011/058087 WO2011144677A1 (en)	2010-05-18	2011-05-18	Pharmaceutical composition of ibuprofen for injection

Publications (2)

Publication Number	Publication Date
PL2571488T3 PL2571488T3 (pl)	2014-12-31
PL2571488T5 true PL2571488T5 (pl)	2018-07-31

Family

ID=43589415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11720479T PL2571488T5 (pl)	2010-05-18	2011-05-18	Kompozycja farmaceutyczna ibuprofenu do iniekcji

Country Status (35)

Country	Link
US (1)	US9114165B2 (pl)
EP (1)	EP2571488B2 (pl)
JP (1)	JP6018048B2 (pl)
KR (1)	KR101770808B1 (pl)
CN (1)	CN102892410B (pl)
AU (1)	AU2011254583B2 (pl)
BR (1)	BR112012029171B1 (pl)
CA (1)	CA2798575C (pl)
CL (1)	CL2012003119A1 (pl)
CO (1)	CO6650419A2 (pl)
CR (1)	CR20120559A (pl)
CY (1)	CY1115394T1 (pl)
DK (1)	DK2571488T4 (pl)
EC (1)	ECSP12012274A (pl)
ES (1)	ES2478491T5 (pl)
HR (1)	HRP20140622T4 (pl)
IL (1)	IL222497A0 (pl)
MA (1)	MA34176B1 (pl)
ME (1)	ME01834B (pl)
MX (1)	MX2012013402A (pl)
MY (1)	MY160302A (pl)
NZ (1)	NZ602957A (pl)
PE (1)	PE20130374A1 (pl)
PH (1)	PH12012502274A1 (pl)
PL (1)	PL2571488T5 (pl)
PT (1)	PT2571488E (pl)
RS (1)	RS53408B2 (pl)
RU (1)	RU2012154628A (pl)
SG (1)	SG185061A1 (pl)
SI (1)	SI2571488T2 (pl)
SM (1)	SMT201400103B (pl)
TN (1)	TN2012000487A1 (pl)
UA (1)	UA103290C2 (pl)
WO (2)	WO2011144766A1 (pl)
ZA (1)	ZA201207948B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9072710B2 (en) *	2012-03-16	2015-07-07	Cumberland Pharmaceuticals Inc.	Injectable ibuprofen formulation
CN104323988A (zh) *	2014-11-27	2015-02-04	北京蓝丹医药科技有限公司	一种用于注射的右旋布洛芬药物组合物
CN105055389B (zh) *	2015-08-03	2018-08-10	北京蓝丹医药科技有限公司	一种用于早产儿先天性心脏病的布洛芬药物组合物
CN105997901A (zh) *	2016-07-27	2016-10-12	济南东方开元医药新技术有限公司	小儿注射用布洛芬氨丁三醇冻干粉针组合物及制备方法
KR20210104039A (ko) *	2018-12-14	2021-08-24	프레제니우스 카비 오스트리아 게엠베하	이부프로펜 및 포스페이트 완충액을 포함하는 비경구 투여용 약학 조성물
CN112526013B (zh) *	2020-11-20	2022-09-06	人福普克药业（武汉）有限公司	超高液相色谱法检测布洛芬药物中有关物质浓度方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19912436A1 (de) *	1999-03-19	2000-09-21	Merckle Gmbh	Ibuprofen-Lösung
US20040132823A1 (en)	2001-11-02	2004-07-08	Leo Pavliv	Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
AU2002224475B2 (en)	2001-11-02	2008-01-17	Cumberland Pharmaceuticals Inc.	Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ITMI20040235A1 (it)	2004-02-13	2004-05-13	Therapicon Srl	Preparazione farmaceutica per il cavo orale

2010
- 2010-05-18 WO PCT/ES2010/070330 patent/WO2011144766A1/es not_active Ceased
2011
- 2011-05-18 ME MEP-2014-74A patent/ME01834B/me unknown
- 2011-05-18 CN CN201180024380.7A patent/CN102892410B/zh not_active Ceased
- 2011-05-18 MX MX2012013402A patent/MX2012013402A/es active IP Right Grant
- 2011-05-18 JP JP2013510623A patent/JP6018048B2/ja active Active
- 2011-05-18 SI SI201130206T patent/SI2571488T2/sl unknown
- 2011-05-18 PT PT11720479T patent/PT2571488E/pt unknown
- 2011-05-18 US US13/641,921 patent/US9114165B2/en active Active
- 2011-05-18 MA MA35330A patent/MA34176B1/fr unknown
- 2011-05-18 PL PL11720479T patent/PL2571488T5/pl unknown
- 2011-05-18 KR KR1020127032850A patent/KR101770808B1/ko active Active
- 2011-05-18 EP EP11720479.2A patent/EP2571488B2/en active Active
- 2011-05-18 PH PH1/2012/502274A patent/PH12012502274A1/en unknown
- 2011-05-18 WO PCT/EP2011/058087 patent/WO2011144677A1/en not_active Ceased
- 2011-05-18 RU RU2012154628/15A patent/RU2012154628A/ru unknown
- 2011-05-18 NZ NZ60295711A patent/NZ602957A/en unknown
- 2011-05-18 HR HRP20140622TT patent/HRP20140622T4/hr unknown
- 2011-05-18 RS RS20140366A patent/RS53408B2/sr unknown
- 2011-05-18 ES ES11720479.2T patent/ES2478491T5/es active Active
- 2011-05-18 MY MYPI2012700890A patent/MY160302A/en unknown
- 2011-05-18 SG SG2012079570A patent/SG185061A1/en unknown
- 2011-05-18 DK DK11720479.2T patent/DK2571488T4/en active
- 2011-05-18 PE PE2012002182A patent/PE20130374A1/es not_active Application Discontinuation
- 2011-05-18 AU AU2011254583A patent/AU2011254583B2/en active Active
- 2011-05-18 CA CA2798575A patent/CA2798575C/en active Active
- 2011-05-18 UA UAA201214485A patent/UA103290C2/ru unknown
- 2011-05-18 BR BR112012029171-8A patent/BR112012029171B1/pt active IP Right Grant
2012
- 2012-10-09 TN TNP2012000487A patent/TN2012000487A1/en unknown
- 2012-10-17 IL IL222497A patent/IL222497A0/en unknown
- 2012-10-17 EC ECSP12012274 patent/ECSP12012274A/es unknown
- 2012-10-22 ZA ZA2012/07948A patent/ZA201207948B/en unknown
- 2012-11-01 CR CR20120559A patent/CR20120559A/es unknown
- 2012-11-07 CL CL2012003119A patent/CL2012003119A1/es unknown
- 2012-12-17 CO CO12228358A patent/CO6650419A2/es unknown
2014
- 2014-07-29 SM SM201400103T patent/SMT201400103B/xx unknown
- 2014-07-30 CY CY20141100574T patent/CY1115394T1/el unknown

Also Published As

Publication number	Publication date
SG185061A1 (en)	2012-12-28
EP2571488B2 (en)	2017-07-26
WO2011144766A1 (es)	2011-11-24
JP2013529205A (ja)	2013-07-18
BR112012029171B1 (pt)	2021-05-25
IL222497A0 (en)	2012-12-31
NZ602957A (en)	2014-09-26
CO6650419A2 (es)	2013-04-15
CY1115394T1 (el)	2017-01-04
KR101770808B1 (ko)	2017-08-23
DK2571488T3 (da)	2014-07-14
MA34176B1 (fr)	2013-04-03
TN2012000487A1 (en)	2014-04-01
MY160302A (en)	2017-02-28
KR20130109007A (ko)	2013-10-07
HRP20140622T1 (en)	2014-09-26
US20130231390A1 (en)	2013-09-05
UA103290C2 (ru)	2013-09-25
SI2571488T1 (sl)	2014-09-30
CN102892410A (zh)	2013-01-23
ES2478491T3 (es)	2014-07-22
HRP20140622T4 (hr)	2017-10-06
EP2571488B1 (en)	2014-06-18
CR20120559A (es)	2013-02-15
AU2011254583B2 (en)	2014-04-10
ME01834B (me)	2014-12-20
HK1177424A1 (en)	2013-08-23
US9114165B2 (en)	2015-08-25
CL2012003119A1 (es)	2013-06-07
PH12012502274A1 (en)	2013-02-04
PT2571488E (pt)	2014-07-25
ECSP12012274A (es)	2013-02-28
WO2011144677A1 (en)	2011-11-24
RU2012154628A (ru)	2014-06-27
RS53408B2 (sr)	2018-06-29
SI2571488T2 (sl)	2017-09-29
ES2478491T5 (es)	2017-11-21
PE20130374A1 (es)	2013-03-30
EP2571488A1 (en)	2013-03-27
RS53408B (en)	2014-10-31
CA2798575A1 (en)	2011-11-24
CN102892410B (zh)	2014-12-10
ZA201207948B (en)	2013-06-26
BR112012029171A2 (pt)	2017-07-18
SMT201400103B (it)	2014-09-08
MX2012013402A (es)	2013-01-17
CA2798575C (en)	2018-08-28
JP6018048B2 (ja)	2016-11-02
PL2571488T3 (pl)	2014-12-31
DK2571488T4 (en)	2017-08-28
AU2011254583A1 (en)	2012-11-08

Publication	Publication Date	Title
SMT201700008B (it)	2017-03-08	Composizione farmaceutica
LT3222272T (lt)	2021-12-27	Farmacinė karbetocino kompozicija
SMT201600350B (it)	2016-11-10	Composizioni farmaceutiche
DK2694038T3 (da)	2019-08-19	Farmaceutisk sammensætning
DK2632493T3 (da)	2016-03-14	Lægemiddelindgivelsessammensætninger
BR112014003052A2 (pt)	2017-03-01	composições farmacêuticas
DK2654736T3 (da)	2020-09-14	Hidtil ukendt farmaceutisk sammensætning
CO6852076A2 (es)	2014-01-30	Composiciones farmacéuticas inhalables
EE201300005A (et)	2013-08-15	Ravimkoostis
CO6930367A2 (es)	2014-04-28	Composiciones farmaceúticas
GT201200303A (es)	2014-04-29	Formulaciones farmacéuticas
BR112013014644A2 (pt)	2017-03-07	composição farmacêutica e complexo
EP2702989A4 (en)	2014-12-31	STABLE PHARMACEUTICAL COMPOSITION
EP2642979A4 (en)	2014-09-17	PHARMACEUTICAL COMPOSITION
HUE040370T2 (hu)	2019-03-28	Gyógyszerkészítmények
DK2542224T3 (da)	2014-10-20	Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
BR112013000356A2 (pt)	2016-06-07	formulação farmacêutica injetável de malfalano
CO6801722A2 (es)	2013-11-29	Composiciones farmacéuticas
SMT201600097B (it)	2016-04-29	Composizione farmaceutica liquida che comprende nitisone
EP2769718A4 (en)	2015-07-01	MEDICAL COMPOSITION
SMT201500005B (it)	2015-05-05	Composizione framaceutica inalabile
SMT201400103B (it)	2014-09-08	Composizione farmaceutica di ibuprofene per iniezione
BR112012003149A2 (pt)	2016-03-01	composição farmacêutica
BR112012029461A2 (pt)	2017-03-01	composição farmacêutica contendo solifenacina
BR112012029887A2 (pt)	2016-08-16	composição farmacêutica